http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H10177027-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c7ad58d3c0b071069a8ee0cb8c8ba2e8
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-975
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57434
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-536
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
filingDate 1997-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d45f8420face1ad0f6d0480809ce27e1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a35766a7ca305da2478641e7a498e17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_392f97477aca7bdfd6272564897c5a99
publicationDate 1998-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H10177027-A
titleOfInvention Measurement method of cPSA
abstract PROBLEM TO BE SOLVED: To provide a free PSA (fPS) by processing a blood sample. Provided is a method for measuring a complex form of immunologically measurable prostate specific antigen (cPSA) in a blood sample, which makes A) immunologically undetectable, such as a two-site immunoassay. SOLUTION: The immunoassay method comprises the following three anti-PSA Antibodies: an antibody that binds both cPSA and fPSA (anti-tPSA), a second anti-tPSA antibody characterized by the unique property that binding to fPSA is blocked by binding of an fPSA-specific antibody, and fPA. A third antibody that is an SA-specific antibody is used. By binding of the fPSA-specific antibody to PSA in the sample, only cPSA is measured in the immunoassay. cP Measuring blood levels of SA provides a sensitive and highly specific method to aid in the diagnosis and monitoring of prostate cancer, and the need to perform unnecessary prostate biopsies for many patients Disappears.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007519913-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007502404-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-4903585-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016042083-A
priorityDate 1996-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP33619
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID656580
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP86348
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3818
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID292872
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP21948
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID16621
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP83456
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ05700
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414813066
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID378
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419482895
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP02701
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ6DT45
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25048
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO60109
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID719444
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81800
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19147
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00634
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP07288
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ05205
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID77890
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID354
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419477924

Total number of triples: 47.